• 1:中华人民共和国国家卫生和计划生育委员会

摘要(Abstract)：

<正>1范围本文规范了宫颈癌的规范化诊治流程、诊断依据、诊断和鉴别诊断、治疗原则及治疗方案。用于农村重大疾病医疗保障工作定点医院对乳腺癌的诊断和治疗。2术语和定义下列术语和定义适用于本标准。宫颈癌前病变是指宫颈上皮内瘤变(CIN),是一组病变的统称,包括宫颈不典型增生和原位癌,为宫颈浸润癌的癌前期病变。此类病变仍限于宫颈

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author):

参考文献(References)：

• [1]Jemal A,Siegel R,Ward E,et al.Cancer Statistics,2007[J].CA Cancer J Clin,2007,57:43-66.
• [2]Howe HL,Wu X,Ries LA,et al.Annual report to the nation on the status of cancer,1975-2003,featuring cancer among U.S.Hispanic/Latino populations[J].Cancer,2006,107(8):1711-1742.
• [3]Sherman ME,Wang SS,Carreon J,et al.Mortality trends for cervical squamous and adenocarcinoma in the United States.Relation to incidence and survival[J].Cancer,2005,103(6):1258-1264.
• [4]Parkin DM,Bray F,Ferlay J.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55:74-108.
• [5]Kamangar F,Dores GM,Anderson WF.Patterns of cancer incidence,mortality,and prevalence across five continents:defining priorities to reduce cancer disparities in different geographic regions of the world[J].J Clin Oncol,2006,24(14):2137-2150.
• [6]Villa LL,Costa RL,Petta CA,et al.Prophylactic quadrivalent human papillomavirus(types 6,11,16,and 18)L1 virus-like particle vaccine in young women:a randomized double-blind placebo-controlled multicentre phase II efficacy trial[J].Lancet Oncol,2005,6:271-278.
• [7]Ault KA,Future Ⅱ Study Group.Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2,grade 3,and adenocarcinoma in situ:a combined analysis of four randomised clinical trials[J].Lancet,2007,369(9576):1861-1868.
• [8]FUTURE Ⅱ Study Group.Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions[J].N Engl J Med,2007,356(19):1915-1927.
• [9]Arbyn M,Dillner J.Review of current knowledge on HPV vaccination:an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening[J].J Clin Virol,2007,38(3):189-197.
• [10]American College of Obstetricians and Gynecologists.ACOG practice bulletin.Diagnosis and treatment of cervical carcinomas[J].Int J Gynaecol Obstet,2002,78:79-91.
• [11]Chi DS.Laparoscopy in gynecologic malignancies[J].Oncology,1999,13:773-782.
• [12]Benedet JL,Bender H,Jones H 3rd,et al.FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers.FIGO Committee on Gynecologic Oncology[J].Int J Gynaecol Obstet,2000,70:209-262.
• [13]Landoni F,Maneo A,Colombo A,et al.Randomized study of radical surgery vs.radiotherapy for stage Ib-IIa cervical cancer[J].Lancet,1997,350:535-540.
• [14]Rose PG,Ali S,Watkins E,et al.Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin,cisplatin-based combination chemotherapy,or hydroxyurea during pelvic irradiation for locally advanced cervical cancer:a Gynecologic Oncology Group Study[J].J Clin Oncol,2007,25(19):2804-2810.
• [15]Monk BJ,Tewari KS,Koh W-J.Multimodality therapy for locally advanced cervical carcinoma:state of the art and future directions[J].J Clin Oncol,2007,25:2952-2965.
• [16]Pearcey R,Miao Q,Kong W,et al.Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario:results of a population-based cohort study[J].J Clin Oncol,2007,25(17):2383-2388.
• [17]Haie-Meder C,Fervers B,Fondrinier E,et al.SOR guidelines for concomitant chemoradiotherapy for patients with uterine cervical cancers:evidence update bulletin 2004[J].Ann Oncol,2005,16:1100-1108.
• [18]Koliopoulos G,Sotiriadis A,Kyrgiou M,et al.Conservative surgical methods for FIGO stage IA2 squamous cervical carcinoma and their role in preserving women's fertility[J].Gynecol Oncol,2004,93:469-473.
• [19]Bernardini M,Barrett J,Seaward G,et al.Pregnancy outcomes in patients after radical trachelectomy[J].Am J Obstet Gynecol,2003,189:1378-1382.
• [20]Boss EA,van Golde RJ,Beerendonk CC,et al.Pregnancy after radical trachelectomy:A real option?[J]Gynecol Oncol,2005,99:S152-S156.
• [21]Plante M,Renaud MC,Hoskins IA,et al.Vaginal radical trachelectomy:a valuable fertility-preserving option in the management of early-stage cervical cancer.A series of 50pregnancies and review of the literature[J].Gynecol Oncol,2005,98(1):3-10.
• [22]Marchiole P,Benchaib M,Buenerd A,et al.Oncological safety of laparoscopic-assisted vaginal radi cal trachelectomy(LARVT or(LARVH).Gynecol Oncol Dargent's operation)[J]:A comparative study with laparoscopic-assisted vaginal radical hysterectomy,2007,106(1):132-141.
• [23]Shepherd JH,Spencer C,Herod J,et al.Radical vaginal trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer-cumulative pregnancy rate in a series of 123 women[J].BJOG,2006,113(6):719-724.
• [24]Landoni F,Zanagnolo V,Lovato-Diaz L,et al.Ovarian metastases in early-stage cervical cancer(IA2-IIA):a multicenter retrospective study of 1965 patients(a Cooperative Task Force study)[J].Int J Gynecol Cancer,2007,17(3):623-628.
• [25]Shimada M,Kigawa J,Nishimura R,et al.Ovarian metastasis in carcinoma of the uterine cervix[J].Gynecol Oncol,2006,101(2):234-237.
• [26]Keys HM,Bundy BN,Stehman FB,et al.Cisplatin,radiation,and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma[J].N Engl J Med,1999,340:1154-1161.
• [27]Morris M,Eifel PJ,Lu J,et al.Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer[J].N Engl J Med,1999,340:1137-1143.